Therapeutic angiogenesis inhibitors in the treatment of cancer.
Hidalgo
M
M
Division of Oncology, University of Texas Health Science Center at San Antonio, USA.
Pierson
A S
AS
Holden
S N
SN
Bergen
M
M
Eckhardt
S G
SG
D000077584:2-Methoxyestradiol; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003094:Collagen / Q000627:therapeutic use; D043169:Endostatins; D016228:Endothelial Growth Factors / Q000276:immunology; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use; D008222:Lymphokines / Q000276:immunology; D061965:Matrix Metalloproteinase Inhibitors; D009369:Neoplasms / Q000188:drug therapy*; D009930:Organic Chemicals; D010446:Peptide Fragments / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D013792:Thalidomide / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D043169:Endostatins; D016228:Endothelial Growth Factors; D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; D008222:Lymphokines; D061965:Matrix Metalloproteinase Inhibitors; D009930:Organic Chemicals; D010446:Peptide Fragments; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C113282:prinomastat; D004958:Estradiol; D013792:Thalidomide; D000077584:2-Methoxyestradiol; D003094:Collagen; C100342:marimastat; D011505:Protein-Tyrosine Kinases